Molecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia

Simple item page
dc.contributor.authorBottomley, S.
dc.contributor.authorMay, B.
dc.contributor.authorCox, T.
dc.contributor.authorCotter, P.
dc.contributor.authorBishop, D.
dc.date.issued1995
dc.description.abstractThe erythroid-specific isozyme of 5-aminolevulinate synthase (ALAS2), the first and ratelimiting enzyme of heme biosynthesis, is expressed concomitantly with the differentiation and maturation of the erythroid cell in order to accommodate generation of the large amounts of heme required for hemoglobin production. During the past few years the ALAS2 gene and its transcript have been characterized and the amino acid sequence of the enzyme deduced. The human genetic disorder X-linked sideroblastic anemia, previously postulated to be caused by defects of ALAS, has now been analyzed at the molecular and tissue-specific level. A heterogeneous group of point mutations in the catalytic domain of the ALAS2 enzyme has been found to cause the disorder. Impaired activity of recombinant mutant ALAS2 enzymes has also been demonstrated. Characterization of molecular defects in individuals with X-linked sideroblastic anemia has provided improved diagnosis for at-risk family members.
dc.description.statementofresponsibilityBottomley, Sylvia; May, Brian; Cox, Timothy; Cotter, Philip; Bishop, David
dc.identifier.citationJournal of Bioenergetics and Biomembranes, 1995; 27(2):161-168
dc.identifier.doi10.1007/BF02110031
dc.identifier.issn0145-479X
dc.identifier.issn1573-6881
dc.identifier.urihttp://hdl.handle.net/2440/11301
dc.language.isoen
dc.publisherPlenum Publishing Corporation
dc.source.urihttps://doi.org/10.1007/bf02110031
dc.titleMolecular defects of erythroid 5-aminolevulinate synthase in X-linked sideroblastic anemia
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Biochemistry publications